News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
54,823 Results
Type
Article (1216)
Company Profile (3)
Press Release (53604)
Section
Business (14764)
Career Advice (121)
Deals (3696)
Drug Delivery (6)
Drug Development (5173)
Employer Resources (8)
FDA (1410)
Job Trends (936)
News (25381)
Policy (1870)
Tag
Academia (132)
Accelerated approval (2)
Allergies (14)
Alliances (4466)
ALS (17)
Alzheimer's disease (117)
Antibody-drug conjugate (ADC) (29)
Approvals (1436)
Artificial intelligence (69)
Autoimmune disease (17)
Automation (5)
Bankruptcy (18)
Best Places to Work (809)
BIOSECURE Act (1)
Biosimilars (6)
Biotechnology (6)
Bladder cancer (18)
Brain cancer (4)
Breast cancer (36)
Cancer (390)
Cardiovascular disease (20)
Career advice (86)
CAR-T (43)
CDC (1)
Cell therapy (99)
Cervical cancer (1)
Clinical research (4652)
Collaboration (134)
Compensation (72)
Complete response letters (3)
COVID-19 (134)
CRISPR (15)
C-suite (29)
Cystic fibrosis (24)
Data (548)
Denatured (2)
Depression (7)
Diabetes (29)
Diagnostics (689)
Digital health (2)
Diversity (1)
Diversity, equity & inclusion (5)
Drug discovery (20)
Drug pricing (5)
Duchenne muscular dystrophy (10)
Earnings (7141)
Editorial (1)
Employer branding (2)
Employer resources (7)
Events (7265)
Executive appointments (37)
FDA (1714)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (87)
Gene editing (23)
Generative AI (8)
Gene therapy (41)
GLP-1 (28)
Government (149)
Guidances (56)
Healthcare (1276)
HIV (1)
IgA nephropathy (12)
Immunology and inflammation (19)
Immuno-oncology (6)
Indications (4)
Infectious disease (146)
Inflammatory bowel disease (6)
Inflation Reduction Act (1)
Influenza (5)
Intellectual property (24)
Interviews (13)
IPO (1815)
IRA (1)
Job creations (143)
Job search strategy (71)
JPM (2)
Layoffs (10)
Legal (364)
Liver cancer (5)
Longevity (1)
Lung cancer (46)
Lymphoma (47)
Machine learning (8)
Management (2)
Manufacturing (56)
MASH (11)
Medical device (1338)
Medtech (1341)
Mergers & acquisitions (2055)
Metabolic disorders (52)
Multiple sclerosis (23)
NASH (1)
Neurodegenerative disease (17)
Neuropsychiatric disorders (4)
Neuroscience (220)
NextGen: Class of 2026 (507)
Non-profit (207)
Obesity (15)
Opinion (14)
Ovarian cancer (17)
Pain (13)
Pancreatic cancer (17)
Parkinson's disease (27)
Partnered (5)
Patents (58)
Patient recruitment (37)
Peanut (5)
People (2981)
Pharmaceutical (4)
Phase 1 (1411)
Phase 2 (2078)
Phase 3 (1536)
Pipeline (590)
Policy (7)
Postmarket research (121)
Preclinical (619)
Press Release (1)
Prostate cancer (13)
Psychedelics (6)
Radiopharmaceuticals (15)
Rare diseases (74)
Real estate (360)
Recruiting (4)
Regulatory (1663)
Reports (4)
Research institute (108)
Resumes & cover letters (43)
Rett syndrome (6)
RNA editing (1)
RSV (1)
Schizophrenia (5)
Series A (10)
Series B (9)
Sickle cell disease (13)
Spinal muscular atrophy (7)
Sponsored (2)
Startups (215)
Stomach cancer (1)
Supply chain (3)
Tariffs (1)
Vaccines (39)
Venture capital (2)
Weight loss (3)
Women's health (4)
Date
Last 7 days (48)
Last 30 days (178)
Last 365 days (2535)
2026 (228)
2025 (2609)
2024 (2965)
2023 (3241)
2022 (4281)
2021 (4694)
2020 (4268)
2019 (3367)
2018 (2729)
2017 (2363)
2016 (2190)
2015 (2898)
2014 (2048)
2013 (1713)
2012 (2117)
2011 (2290)
2010 (1987)
Location
Africa (46)
Alabama (7)
Arizona (10)
Arkansas (2)
Asia (2536)
Australia (564)
California (937)
Canada (400)
China (62)
Colorado (49)
Connecticut (79)
Delaware (42)
Europe (5650)
Florida (128)
Georgia (18)
Idaho (3)
Illinois (74)
India (3)
Indiana (40)
Japan (25)
Kansas (40)
Kentucky (3)
Louisiana (7)
Maine (2)
Maryland (138)
Massachusetts (751)
Michigan (15)
Minnesota (31)
Mississippi (1)
Missouri (10)
Nebraska (2)
Nevada (7)
New Hampshire (16)
New Jersey (299)
New Mexico (2)
New York (184)
North Carolina (56)
North Dakota (2)
Northern California (510)
Ohio (32)
Oklahoma (1)
Oregon (3)
Pennsylvania (188)
Puerto Rico (1)
Rhode Island (3)
South America (50)
South Carolina (3)
Southern California (340)
Tennessee (9)
Texas (219)
United States (3408)
Utah (43)
Virginia (12)
Washington D.C. (1)
Washington State (70)
Wisconsin (15)
Wyoming (1)
54,823 Results for "misonix incorporated".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Hollister Incorporated Awarded Multiple Contract Agreements with Premier, Inc.
January 20, 2026
·
3 min read
Press Releases
PharmAla Incorporates Australian Entity for Clinical Research
September 4, 2025
·
4 min read
Press Releases
Hollister Incorporated Drives Major Policy Change to Expand Access to Closed System Intermittent Catheters for People with Spinal Cord Injuries
November 24, 2025
·
3 min read
Press Releases
Tisento Therapeutics Announces Publication of MELAS Interview Study, Incorporating Patients’ Perspectives to Elucidate Symptoms and Impacts of Rare Mitochondrial Disease
November 4, 2025
·
5 min read
Deals
Bioventus and Misonix Stockholders Approve the Acquisition of Misonix by Bioventus
Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), and Misonix, Inc. (Nasdaq: MSON) (“Misonix”), today announced that the stockholders of Bioventus approved the issuance of shares of Bioventus class A common stock to the stockholders of Misonix in connection with the previously announced Agreement and Plan of Merger, dated July 29, 2021,
October 26, 2021
·
6 min read
Deals
Bioventus Completes the Acquisition of Misonix
Bioventus Inc. has completed the acquisition of Misonix, Inc. (“Misonix”), a provider of minimally invasive therapeutic ultrasonic technologies and regenerative medicine that are designed to enhance clinical outcomes, for cash and common stock.
October 29, 2021
·
6 min read
Press Releases
Ambry Genetics Announces Improved EHR-Integrated Breast Cancer Risk Assessment Solution with Upgraded Tyrer-Cuzick Scoring Approach Incorporating Breast Density
October 2, 2025
·
8 min read
Press Releases
Receptor.AI Incorporates The REAXENSE Platform to Expand Full-Stack Drug Discovery Capabilities
June 12, 2025
·
1 min read
Pharm Country
Misonix Receives Health Canada Approval for neXus
Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that it has received a Health Canada license for the neXus® Ultrasonic Surgical System.
March 4, 2021
·
2 min read
Pharm Country
Misonix to Participate at Upcoming Investor Conferences
Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that Misonix Chief Executive Officer, Stavros Vizirgianakis, along with Joe Dwyer, Chief Financial Officer, will be participating in two upcoming investor conferences. BTIG Virtual MedTech, Digital Health, Life Science & Diagnostics Tools Conference Dates: F
February 11, 2021
·
1 min read
1 of 5,483
Next
